BlackRock, Inc. 13D and 13G filings for ADMA Biologics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-07 4:08 pm Purchase | 2024-09-30 | 13G | ADMA Biologics, Inc. ADMA | BlackRock Inc. BLK | 38,269,434 16.400% | 20,351,689 (+113.58%) | Filing |
| 2024-01-26 11:49 am Purchase | 2023-12-31 | 13G | ADMA Biologics, Inc. ADMA | BlackRock Inc. BLK | 17,917,745 7.900% | 2,816,464 (+18.65%) | Filing |
| 2023-02-03 12:10 pm Purchase | 2022-12-31 | 13G | ADMA Biologics, Inc. ADMA | BlackRock Inc. BLK | 15,101,281 6.900% | 9,347,461 (+162.46%) | Filing |
| 2021-04-09 6:02 pm Purchase | 2021-03-31 | 13G | ADMA Biologics, Inc. ADMA | BlackRock Inc. BLK | 5,753,820 4.700% | 330,121 (+6.09%) | Filing |
| 2021-02-02 2:56 pm Purchase | 2020-12-31 | 13G | ADMA Biologics, Inc. ADMA | BlackRock Inc. BLK | 5,423,699 5.700% | 1,250,938 (+29.98%) | Filing |
| 2020-03-09 4:26 pm Purchase | 2020-02-29 | 13G | ADMA Biologics, Inc. ADMA | BlackRock Inc. BLK | 4,172,761 4.800% | 201,654 (+5.08%) | Filing |